Cell-free Assays (IC50/Ki) for AMD3100 (Plerixafor)
| Key Target | IC50 (Cell-free) | Description | Reference |
|---|---|---|---|
| Escherichia coli S30 extract system | 62.30 ±6.47mM | luciferase-based in vitro protein synthesis assay | PMC13055176 |
| CXCR4 | 11.4 µM | Molecular docking (Ki value) | Download PDF |
| TGFβ-1 | 9.1 µM | Molecular docking (Ki value) | Download PDF |
Cell-based Assay (IC50) for AMD3100 (Plerixafor)
| Cell Type | IC50 (Cell-based) | Description | Reference |
|---|---|---|---|
| HEK293T cells (CXCR4) | 101.6 nM | NanoBiT protein–protein-interaction assay system, luminescence signal measurement, AUC determination. | Download PDF |
| CXCR4 in HEK293 cells | 0.2 µM (pIC50 of 6.7 ± 0.09) | Inositol triphosphate (IP3) accumulation assay | Download PDF |
| membranes of CXCR4-mEGFP expressing Flp-In T-REx 293 cells | 3.9 × 10−7M | [35S]GTPγS binding assay | Download PDF |
| Jurkat cells | 100μM | Microscopical evaluation and CellTiter 96 Aqueous One Solution Cell Proliferation Assay (MTS method) | Download PDF |
| MT-4 cells | >100μM | Microscopical evaluation and CellTiter 96 Aqueous One Solution Cell Proliferation Assay (MTS method) | Download PDF |
| PHA-stimulated PBMCs | >100μM | Microscopical evaluation and CellTiter 96 Aqueous One Solution Cell Proliferation Assay (MTS method) | Download PDF |
| Jurkat cells | 12.0±1.1 nM | Flow cytometry (FACSArray) to quantify fluorescent signal of specific CXCL12AF647 binding | Download PDF |
| U87.CD4.CXCR4 cells | 723.0±99.1 nM | FLIPR Tetra system to measure intracellular calcium fluxes | Download PDF |
| SUP-T1 cells | 148.0±36.0 nM | Flow cytometry (FACSCalibur) to quantify the degree of receptor internalization | Download PDF |
| Jurkat cells | 1,431±485 nM | Flow cytometry (FACSCanto II) to count migrated cells | Download PDF |
| MT-4 cells | 11.8±3.4 nM | MTS method to assess cell viability | Download PDF |
| PHA-stimulated PBMCs | 14.9±3.2 nM | HIV-1 p24 core antigen enzyme-linked immunosorbent assay (ELISA) | Download PDF |
| MCF7(TAM-R) cells | 2.55 x 10^-7 M | SP analysis | PMC3389396 |
Check the
AMD3100 (Plerixafor)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- AMD3100 (Plerixafor) Mechanism of Action: CXCR4 Inhibition in Immune Cell Research
- AMD3100 (Plerixafor) Clinical Trials
- AMD3100 (Plerixafor) Working Concentration | Cell Culture | Treatment
- AMD3100 (Plerixafor) Solubility in DMSO
- AMD3100 (Plerixafor) Stock Solution
- AMD3100 (Plerixafor) Storage
- AMD3100 (Plerixafor) Stability
- AMD3100 (Plerixafor) Combination Database
- AMD3100 (Plerixafor) Molecular Weight
- AMD3100 (Plerixafor) SMILES
- AMD3100 (Plerixafor) CAS Number
- AMD3100 (Plerixafor) Chemical Structure (2D and 3D)
- AMD3100 (Plerixafor) Sigma (1545135)? Try a better option.
- AMD3100 (Plerixafor) MedChemExpress (HY-10046)? Try a better option.
- AMD3100 (Plerixafor) Cayman (35579)? Try a better option.
- AMD3100 (Plerixafor) APExBIO (A2025)? Try a better option.
- AMD3100 (Plerixafor) SDS|MSDS